Chimeric Antigen Receptor T-cell therapy in 2020: Current Indications
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP
Disclosure
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP discloses no such relationships exist
Accreditation
NA
